Fact Sheet for Healthcare Providers: ACCESS SARS‐CoV‐2 IgM | NLM

Disaster Information Management Research Center | NLM

Fact Sheet for Healthcare Providers: ACCESS SARS‐CoV‐2 IgM

10/08/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 10/8/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Access SARS‐CoV‐2 IgM. The Access SARS‐CoV‐2 IgM is authorized for the detection of antibodies to SARS-CoV-2 in human serum and plasma. (PDF)